CLOV CLOVER HEALTH INVESTMENTS CO
FollowCOMMON STOCK (common), issuer CIK 1801170
Filings received so far for Q3 2026: 8 13F filers report a position in CLOV shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Reynoso Jamie L.officer (CEO, Medicare Advantage) | 2026-10-07 | -2,006 S | $4.63 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Farther Finance Advisors, LLC | 267,508 | $1.15M | 0.01% | +1,868 | 13F-HRTimeline |
| Silverleafe Capital Partners, LLC | 40,000 | $172K | 0.05% | 0 | 13F-HRTimeline |
| Everhart Financial Group, Inc. | 12,546 | $54.1K | <0.01% | 0 | 13F-HRTimeline |
| Ballew Advisors, Inc | 10,000 | $43.8K | 0.02% | new | 13F-HRTimeline |
| GK Wealth Management LLC | 3,978 | $17.1K | 0.01% | new | 13F-HRTimeline |
| Versant Capital Management, Inc | 144 | $621 | <0.01% | new | 13F-HRTimeline |
| GAMMA Investing LLC | 129 | $556 | <0.01% | -17 | 13F-HRTimeline |
| CoreCap Advisors, LLC | 100 | $431 | <0.01% | 0 | 13F-HRTimeline |
Events
Reynoso Jamie L. sold 2,006 CLOV shares on 2026-10-07, Form 4 filed 2026-10-07. 0001839066-26-000054
Accepted , ingested